Bionano Genomics, Inc.: shareholders and insiders

BNGONASDAQHealthcare · Laboratory Analytical Instruments

Price

$0.89

November 20, 2026Market cap $12M

What Ploutos Investor adds for Bionano Genomics

Part of Ploutos Investor, €9.99 a month

See the plans
  • The full history: 9 fiscal years, from 2017
  • The estimated fair value, with its range and its certainty
  • The full analysis, 18 a month
  • More questions to the chat on its filings
  • Excel with every year
  • An email when it reports, changes its dividend or an officer buys

Sign in with a free account to see the last 5 fiscal years.

Notes on these figures

  • The share price has fallen 28% since Nov 10, 2026, when the 10-Q these figures come from was filed ($1.23 then, $0.89 on Nov 19, 2026). The figures date from before that move.10-Q

Insiders and their shares

Purchases and sales by officers and directors from Nov 20, 2025 to Sep 9, 2026, from their own Form 4 filings.

10 Form 4s

Bought on the market

$9.7K

1 person

Sold on the market

–

nobody

From Nov 20, 2025 to Nov 20, 2026, the days the chart shows. Change its range and the figures follow.

How the sales were made, as a share of their value

No sales in the period.

  • Sep 4, 2026Albert LudererInterim Chief Executive
    Kind
  • Aug 21, 2026Albert LudererInterim Chief Executive
    Kind
  • Jun 3, 2026Jonathan V. DixonGENERAL COUNSEL
    Kind
  • Jun 3, 2026Mark OldakowskiCHIEF OPERATING OFFICER
    Kind
  • Jun 3, 2026Alka ChaubeyCHIEF MEDICAL OFFICER
    Kind
  • Jun 3, 2026Mark AdamchakPrincipal Accounting Officer
    Kind

From the Form 4s insiders file with the SEC within two business days of each trade.

Insiders and their shares

Every buy and sale by BNGO's officers and directors from 2018 up to November 19, 2025, 8 more calendar years

Part of Ploutos Investor, €9.99 a month

See the plans

Sign in with a free account to see the last 3 years.

Major holders (over 5%)

Whoever comes to own more than 5% of a class of shares reports it to the SEC on Schedule 13D or 13G. Here is each holder's latest filing.

5 Holders over 5%Oct 19, 2026 Latest filing
  • Ayrton Capital LLCwith 2 more persons
    Share of class9.99%
  • CVI Investments, Inc.with 1 more person
    Share of class9.90%
  • Orin Hirschmanwith 1 more person
    Share of class9.90%
  • Lind Global Fund III LPwith 2 more persons
    Share of class9.35%
  • Lincoln Alternative Strategies LLC
    Share of class5.42%
Fell to 5% or less (2)

Holders whose latest filing says they hold 5% or less. After it they need not file again, so what they hold today is not known.

  • Iroquois Capital Management, LLC4.99%Nov 14, 202513G/A
  • Mitchell P. Kopin4.99%Sep 19, 202513G

From the Schedule 13D and 13G filed with the SEC since Dec 18, 2024, when they became structured data. A holder who has filed nothing since then is not shown here. A 13D is updated within two business days of any material change, a 13G up to 45 days after the quarter of the change, so the shares are those of the filing. The large managers also appear in the 13Fs.

Well-known managers

Which of the about 30 investment managers we track held the shares at the quarter end, and what they changed from the quarter before.

Sep 30, 2026 quarter end
  • Citadel Advisors (Griffin)
    In the quarter
  • Renaissance Technologies
    In the quarter+201%

From the 13Fs managers file with the SEC up to 45 days after each quarter end. They show only long positions on that day, not short sales or what has changed since. No recent 13F: Pershing Square (Ackman), Scion (Burry).

Short interest

How many of the company's shares have been sold borrowed and not yet bought back, twice a month.

On Oct 15, 2026, 9.72% of its shares outstanding were held short, -33.2% since the report before.

Shares held short
1.36M
9.72%
Since the report before2.04M on Sep 30, 2026
-33.2%
5.7
238.3K
More days to cover thanof 4,578 US-listed companies with enough volume
68%
Report date
Oct 15, 2026
  • Oct 31, 2023: Shares held short 6.61M
  • Nov 15, 2023: Shares held short 7.08M
  • Nov 30, 2023: Shares held short 5.54M
  • Dec 15, 2023: Shares held short 5.14M
  • Dec 29, 2023: Shares held short 5.06M
  • Jan 12, 2024: Shares held short 4.89M
  • Jan 31, 2024: Shares held short 5.60M
  • Feb 15, 2024: Shares held short 5.63M
  • Feb 29, 2024: Shares held short 5.23M
  • Mar 15, 2024: Shares held short 5.47M
  • Mar 28, 2024: Shares held short 5.27M
  • Apr 15, 2024: Shares held short 5.36M
  • Apr 30, 2024: Shares held short 5.15M
  • May 15, 2024: Shares held short 4.98M
  • May 31, 2024: Shares held short 4.69M
  • Jun 14, 2024: Shares held short 5.25M
  • Jun 28, 2024: Shares held short 5.77M
  • Jul 15, 2024: Shares held short 4.81M
  • Jul 31, 2024: Shares held short 4.47M
  • Aug 15, 2024: Shares held short 4.23M
  • Aug 30, 2024: Shares held short 3.68M
  • Sep 13, 2024: Shares held short 4.16M
  • Sep 30, 2024: Shares held short 6.07M
  • Oct 15, 2024: Shares held short 7.67M
  • Oct 31, 2024: Shares held short 9.83M
  • Nov 15, 2024: Shares held short 12.11M
  • Nov 29, 2024: Shares held short 12.66M
  • Dec 13, 2024: Shares held short 15.84M
  • Dec 31, 2024: Shares held short 17.65M
  • Jan 15, 2025: Shares held short 20.49M
  • Jan 31, 2025: Shares held short 443.9K
  • Feb 14, 2025: Shares held short 471.1K
  • Feb 28, 2025: Shares held short 506.7K
  • Mar 14, 2025: Shares held short 508.2K
  • Mar 31, 2025: Shares held short 587.8K
  • Apr 15, 2025: Shares held short 597.4K
  • Apr 30, 2025: Shares held short 486.2K
  • May 15, 2025: Shares held short 574.3K
  • May 30, 2025: Shares held short 611.1K
  • Jun 13, 2025: Shares held short 549.0K
  • Jun 30, 2025: Shares held short 498.1K
  • Jul 15, 2025: Shares held short 412.5K
  • Jul 31, 2025: Shares held short 332.6K
  • Aug 15, 2025: Shares held short 398.4K
  • Aug 29, 2025: Shares held short 331.3K
  • Sep 15, 2025: Shares held short 706.4K
  • Sep 30, 2025: Shares held short 1.37M
  • Oct 15, 2025: Shares held short 1.04M
  • Oct 31, 2025: Shares held short 904.0K
  • Nov 14, 2025: Shares held short 1.15M
  • Nov 28, 2025: Shares held short 1.10M
  • Dec 15, 2025: Shares held short 956.1K
  • Dec 31, 2025: Shares held short 1.05M
  • Jan 15, 2026: Shares held short 1.05M
  • Jan 30, 2026: Shares held short 1.14M
  • Feb 13, 2026: Shares held short 1.20M
  • Feb 27, 2026: Shares held short 1.17M
  • Mar 13, 2026: Shares held short 1.09M
  • Mar 31, 2026: Shares held short 1.23M
  • Apr 15, 2026: Shares held short 1.15M
  • Apr 30, 2026: Shares held short 1.13M
  • May 15, 2026: Shares held short 1.22M
  • May 29, 2026: Shares held short 1.12M
  • Jun 15, 2026: Shares held short 1.13M
  • Jun 30, 2026: Shares held short 1.16M
  • Jul 15, 2026: Shares held short 1.09M
  • Jul 31, 2026: Shares held short 1.07M
  • Aug 14, 2026: Shares held short 1.15M
  • Aug 31, 2026: Shares held short 1.22M
  • Sep 15, 2026: Shares held short 1.14M
  • Sep 30, 2026: Shares held short 2.04M
  • Oct 15, 2026: Shares held short 1.36M

As brokers report them to the regulator twice a month, mid-month and at month end, published about eight business days later. A short position is shares sold borrowed and not yet bought back. The share count is the one the company's market value is figured on, from its filings. Days to cover is the shares held short over the average daily volume of the weeks between two reports.

Short sales in daily trading47.5% of the shares in the last 14 sessions' reported trades were short sales.

In the last 14 sessions, 47.5% of the shares in the reported trades were short sales, against 51.0% in the 14 before.

Last 14 sessionsNov 2, 2026 – Nov 19, 2026
47.5%
The 14 beforeOct 13, 2026 – Oct 30, 2026
51.0%
Change
-3.5 pts
Short sales a dayon average, of 189.5K shares
90.1K
More than atof 3,666 US-listed companies, same days
39%
Median of alleight in ten from 34.5% to 63.8%
50.4%
  • Oct 13, 2026: Short sales 38.8%
  • Oct 14, 2026: Short sales 41%
  • Oct 15, 2026: Short sales 22.2%
  • Oct 16, 2026: Short sales 45.7%
  • Oct 19, 2026: Short sales 45.5%
  • Oct 20, 2026: Short sales 63.2%
  • Oct 21, 2026: Short sales 46.6%
  • Oct 22, 2026: Short sales 41.3%
  • Oct 23, 2026: Short sales 65.5%
  • Oct 26, 2026: Short sales 53.3%
  • Oct 27, 2026: Short sales 77.5%
  • Oct 28, 2026: Short sales 55.6%
  • Oct 29, 2026: Short sales 52.3%
  • Oct 30, 2026: Short sales 52.2%
  • Nov 2, 2026: Short sales 62.5%
  • Nov 3, 2026: Short sales 35.1%
  • Nov 4, 2026: Short sales 63.5%
  • Nov 5, 2026: Short sales 46.2%
  • Nov 6, 2026: Short sales 56.6%
  • Nov 9, 2026: Short sales 82.8%
  • Nov 10, 2026: Short sales 57.8%
  • Nov 11, 2026: Short sales 45.1%
  • Nov 12, 2026: Short sales 43.6%
  • Nov 13, 2026: Short sales 46.8%
  • Nov 16, 2026: Short sales 30.9%
  • Nov 17, 2026: Short sales 27%
  • Nov 18, 2026: Short sales 14.4%
  • Nov 19, 2026: Short sales 44%

This is not the number of shares sold short today: it measures short sales within each day's trading, and only trades made off the exchanges. Much of it is market makers, who sell shares they do not have to fill buyers' orders and cover soon after, so for a heavily traded stock the share is often around half.

What the insiders hold

The shares each insider reports holding after their latest trade (Form 4), for those who traded on the market in the last three years.

9,980 Insiders' shares0.09% Of the company
  • Albert LudererInterim Chief Executive
    Directly–
  • Mark OldakowskiCHIEF OPERATING OFFICER
    Directly868
  • Alka ChaubeyCHIEF MEDICAL OFFICER
    Directly620
  • Mark AdamchakPrincipal Accounting Officer
    Directly253
  • Jonathan V. DixonGENERAL COUNSEL
    Directly239

A lower bound: it counts only the 5 officers and directors with a market trade since Nov 21, 2023. Anyone who neither bought nor sold since is not here, whatever they hold. The share is against the share count on the latest 10-K's cover.

The ETFs that hold it

Which of the 345 US equity ETFs we track hold the stock, and at what weight, from the funds' N-PORT filings.

1 ETFs holding it0.00% The largest weight (VXF)
  • VXFVanguard Extended Market Index Fund
    Weight in the fund0.00%

1 of the 345 ETFs we track, not of every ETF on the market. The ten largest weights. Positions as each fund filed them in its latest N-PORT.

Institutional investors by quarter

Every manager that reports positions to the SEC (Form 13F), quarter by quarter: how many hold the stock, how many shares and dollars between them, and who entered, left, added or trimmed during the quarter.

33 Managers, Q2 2026$801.6K Value of their positions
  • Q3 2025: Managers 31
  • Q4 2025: Managers 31
  • Q1 2026: Managers 31
  • Q2 2026: Managers 33

Institutional investors by quarter

The fund managers holding BNGO, quarter by quarter, from Q3 2018 to Q2 2025, 23 more quarters

Part of Ploutos Investor, €9.99 a month

See the plans

Sign in with a free account to see the last 12 quarters.

Q2 2026: 33 managers held 709.5K shares, worth $801.6K. During the quarter 8 opened a position, 5 closed one, 11 added and 2 trimmed.

The largest holders, Q2 2026

  • Gsa Capital Partners
    In the quarter-57%
  • Carret Asset Management
    In the quarter+79%
  • Geode Capital Management
    In the quarter-46%
  • Vanguard Capital Management
    In the quarter+21%
  • Vanguard Fiduciary Trust
    In the quarter
  • Renaissance Technologies
    In the quarter+4.9%
  • Jane Street Group
    In the quarter
  • Prudential Financial
    In the quarter+13%
  • Northern Trust
    In the quarter+20%
  • XTX Topco
    In the quarter

From the SEC's Form 13F data sets, Q3 2025 to Q2 2026: the long positions of every manager with more than $100 million under management, as filed up to 45 days after each quarter end. Short positions and options are not in them. Shares as reported each quarter, not adjusted for splits. The stock is matched by its CUSIP, through the SEC's fails-to-deliver files.

Pay against performance, the say-on-pay vote, buybacks by quarter and trading plans are read for S&P 500 companies only.

The full analysis

What do Bionano Genomics's filings show?

Who buys and sells is one part of Bionano Genomics's picture. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.

  • A fair value range built from the filings
  • Earnings quality, debt and red flags
  • Insider and institutional moves
  • The case for and the case against

Questions about BNGO's shareholders

Didn't find what you were looking for?

Ask us
Have BNGO's insiders bought or sold?

From Jun 3, 2026 to Sep 9, 2026 Bionano Genomics's insiders bought $9.7K and sold 0 of shares on the market. – of the sales were under set 10b5-1 plans.

Which well-known managers hold BNGO?

2 of the managers we track held the shares on Sep 30, 2026. The largest position was Renaissance Technologies's, worth $200.0K.

Is every insider transaction a purchase or a sale?

No. Many are part of their pay: share awards, option exercises and shares the company keeps for the tax. Only code P is a purchase with their own money, and code S a sale on the market.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.